Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04737109
Title Neoadjuvant Androgen Deprivation, Darolutamide, and Ipatasertib in Men With Localized, High Risk Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements Yes
Sponsors David VanderWeele
Indications

prostate cancer

Therapies

Darolutamide + Ipatasertib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST